Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Anthropic says distillation campaigns targeted Claude, linking them to DeepSeek, Moonshot, and MiniMax and citing 24,000 fake accounts.
Yan Junjie, the billionaire founder, chairman and CEO of Chinese AI model developer MiniMax Group, has seen his fortune more than double to $7.8 billion on Forbes' World’s Real-Time Billionaires List ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the AI stocks that will go to the moon. On February 18, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) came under pressure after regulatory ...
MiniMax shares surged after revenue beat expectations in its first set of results following its listing. Shares of the Chinese artificial-intelligence company rose 18% to 884.00 Hong Kong dollars, or ...
Anthropic dropped a bombshell on the artificial intelligence industry Monday, publicly accusing three prominent Chinese AI laboratories — DeepSeek, Moonshot AI, and MiniMax — of orchestrating ...
United States artificial intelligence firm Anthropic is accusing three prominent Chinese AI labs of illegally extracting capabilities from its Claude model to advance their own, claiming it raises ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results